Healthy Skepticism Library item: 3511
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: Journal Article
MaLAM letter follow up—Sandoz
MaLAM Newsletter 1987 Jun;
Abstract:
Sandoz maintains that Hydergine is useful for individuals with mental decline but it did not cite any studies to support this position.
Keywords:
*analysis/developing countries/Hydergine/co-dergocrine/Sandoz/company responses/quality of information/MaLAM/Medical Lobby for Appropriate Marketing/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: NEUROLOGIC DISEASES/REGULATION, CODES, GUIDELINES: FEEDBACK TO COMPANIES